X0304 4 2012-02-27 0 0001332283 BlackRock Enhanced Equity Dividend Trust BDJ 0001162744 FELDSTEIN KATHLEEN F 55 EAST 52ND STREET NEW YORK NY 10055 1 0 0 0 Common Stock 2012-02-27 4 J 0 114 A 412 D Common Stock 2012-02-27 4 J 0 104 A 412 D Effective as of February 27, 2012, BlackRock Strategic Equity Dividend Trust (the "Target Fund") was reorganized into BlackRock Enhanced Equity Dividend Trust (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of beneficial interest of the Acquiring Fund in an amount equal to the aggregate net asset value of the Target Fund's common shares as determined at the close of business on February 24, 2012, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of February 24, 2012, the Target Fund reported a net asset value per share of $11.9347 and the Acquiring Fund reported a net asset value per share of $8.4561. The conversion ratio for the Target Fund's common shares was 1.41137167. In the Reorganization, Dr. Kathleen Feldstein received 114 common shares of the Acquiring Fund in exchange for her 81 common shares of the Target Fund. Effective as of February 27, 2012, BlackRock Equity Dividend Trust (the "Target Fund") was reorganized into BlackRock Enhanced Equity Dividend Trust (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of beneficial interest of the Acquiring Fund in an amount equal to the aggregate net asset value of the Target Fund's common shares as determined at the close of business on February 24, 2012, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of February 24, 2012, the Target Fund reported a net asset value per share of $10.8103 and the Acquiring Fund reported a net asset value per share of $8.4561. The conversion ratio for the Target Fund's common shares was 1.27840257. In the Reorganization, Dr. Kathleen Feldstein received 104 common shares of the Acquiring Fund in exchange for her 82 common shares of the Target Fund. /s/ Noah Gellner as Attorney-in-Fact 2012-02-28